Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Conformis Inc. CFMS

Conformis Inc is an us-based medical technology company. It uses the iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped to fit each patient's anatomy. The company's iFit technology platform comprises three key elements which are iFit design, iFit printing, and iFit just-in-time delivery. It offers various partial and total knee replacement implants which include iTotal CR, iTotal PS, iDuo, and iUni. The company operates in the segment of the knee replacement market. Its total revenue is generated from the sale of its products to hospitals and other medical facilities. The majority of the company's revenue comes from the United States.


Recent & Breaking News (NDAQ:CFMS)

Conformis Announces Bart Lagae as VP, International Sales & Marketing; Inducement Grant Reported

GlobeNewswire November 9, 2020

Conformis Reports Third Quarter 2020 Financial Results

GlobeNewswire November 4, 2020

Conformis, Inc. to Participate in the 2020 Oppenheimer Fall MedTech Summit

GlobeNewswire October 28, 2020

Conformis Reports Preliminary Third Quarter Revenue Results

GlobeNewswire October 6, 2020

Conformis Announces 510(k) Clearance for Cordera(TM) Hip System

GlobeNewswire September 29, 2020

Conformis, Inc. Announces $17.25 Million Registered Direct Offering Priced At-The-Market

GlobeNewswire September 24, 2020

Conformis, Inc. to Present at the 2020 Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

GlobeNewswire September 16, 2020

Conformis, Inc. to Present at the 2020 H.C. Wainwright Global Investment Conference

GlobeNewswire September 8, 2020

Conformis, Inc. to Participate in the 2020 Wells Fargo Virtual Healthcare Conference

GlobeNewswire September 2, 2020

Conformis Announces Achievement of Second Milestone Under Development and License Agreements

GlobeNewswire August 20, 2020

Conformis Announces Farzin Khaghani as VP, US Marketing; Inducement Grants Reported

GlobeNewswire August 13, 2020

90% Patient Satisfaction Reported in Peer-Reviewed Clinical Study of Conformis iTotal PS Knee Replacements

GlobeNewswire August 10, 2020

Conformis Reports Second Quarter 2020 Financial Results and Announces Planned Portfolio Expansion Targeted at Ambulatory Surgical Centers

GlobeNewswire August 5, 2020

Conformis, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference

GlobeNewswire July 23, 2020

Conformis Reports Preliminary Second Quarter Revenue Results, Amendment to Credit Agreement

GlobeNewswire July 6, 2020

Conformis Announces 510(k) Clearance for iTotal® Identity PS

GlobeNewswire June 22, 2020

Conformis Announces Settlement of Patent Dispute

GlobeNewswire May 28, 2020

Prestigious Klee Family Foundation Prize 2020 Awarded for Outstanding Scientific Work Identifying Patient-Specific Approach as Better Way to Optimize Knee Implant Design

GlobeNewswire May 21, 2020

Conformis Reports First Quarter 2020 Financial Results

GlobeNewswire May 11, 2020

Conformis to Host First Quarter 2020 Financial Results Webcast on May 11, 2020

GlobeNewswire May 5, 2020